Colibri TAVI System (Second-Generation)
Aortic Stenosis
Feasibility StudyActive
Key Facts
About Colibri Heart Valve
Colibri Heart Valve is an emerging, pre-revenue medical device company developing a disruptive, ready-for-use TAVI system for aortic valve replacement. Its core innovation is a pre-mounted, pre-crimped valve utilizing dry tissue technology, which aims to reduce procedural complexity, improve quality control, and enable a lower delivery profile compared to incumbent systems. The company is in the clinical development stage, having initiated a feasibility study for its second-generation system in 2018, and is positioned to address significant operational inefficiencies in the rapidly growing transcatheter heart valve market.
View full company profile